Artículos de revistas
The Brazilian Consensus For The Diagnosis And Treatment Of Hyperthyroidism: Recommendations By The Thyroid Department Of The Brazilian Society Of Endocrinology And Metabolism [consenso Brasileiro Para O Diagnóstico E Tratamento Do Hipertireoidismo: Recomendações Do Departamento De Tireoide Da Sociedade Brasileira De Endocrinologia E Metabologia]
Registro en:
Arquivos Brasileiros De Endocrinologia E Metabologia. , v. 57, n. 3, p. 205 - 232, 2013.
10.1590/S0004-27302013000300006
2-s2.0-84878024357
Autor
Maia A.L.
Scheffel R.S.
Souza Meyer E.L.
Mazeto G.M.F.S.
de Carvalho G.A.
Graf H.
Vaisman M.
Maciel L.M.Z.
Ramos H.E.
Tincani A.J.
de Andrada N.C.
Ward L.S.
Institución
Resumen
Introduction: Hyperthyroidism is characterized by increased synthesis and release of thyroid hormones by the thyroid gland. Thyrotoxicosis refers to the clinical syndrome resulting from excessive circulating thyroid hormones, secondary to hyperthyroidism or due to other causes. This article describes evidence-based guidelines for the clinical management of thyrotoxicosis. Objective: This consensus, developed by Brazilian experts and sponsored by the Department of Thyroid Brazilian Society of Endocrinology and Metabolism, aims to address the management, diagnosis and treatment of patients with thyrotoxicosis, according to the most recent evidence from the literature and appropriate for the clinical reality of Brazil. Materials and methods: After structuring clinical questions, search for evidence was made available in the literature, initially in the database Medline, PubMed and Embase databases and subsequently in SciELO - Lilacs. The strength of evidence was evaluated by Oxford classification system was established from the study design used, considering the best available evidence for each question. Results: We have defined 13 questions about the initial clinical approach for the diagnosis and treatment that resulted in 53 recommendations, including the etiology, treatment with antithyroid drugs, radioactive iodine and surgery. We also addressed hyperthyroidism in children, teenagers or pregnant patients, and management of hyperthyroidism in patients with Graves' ophthalmopathy and various other causes of thyrotoxicosis. Conclusions: The clinical diagnosis of hyperthyroidism usually offers no difficulty and should be made with measurements of serum TSH and thyroid hormones. The treatment can be performed with antithyroid drugs, surgery or administration of radioactive iodine according to the etiology of thyrotoxicosis, local availability of methods and preferences of the attending physician and patient. 57 3 205 232 Andrade, V.A., Gross, J.L., Maia, A.L., Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism (1999) J Clin Endocrinol Metab., 84 (11), pp. 4012-4016 Boelaert, K., Torlinska, B., Holder, R.L., Franklyn, J.A., Older subjects with hyperthyroidism present with a paucity of symptoms and signs: A large cross-sectional study (2010) J Clin Endocrinol Metab., 95 (6), pp. 2715-2726 Nordyke, R.A., Gilbert Jr., F.I., Harada, A.S., Graves' disease. Influence of age on clinical findings (1988) Arch Intern Med., 148 (3), pp. 626-631 Woeber, K.A., Thyrotoxicosis and the heart (1992) N Engl J Med., 327 (2), pp. 94-98 de los Santos, E.T., Starich, G.H., Mazzaferri, E.L., Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients (1989) Arch Intern Med., 149 (3), pp. 526-532 Rajatanavi, R., Braverman, L.E., Euthyroid hyperthyroxinemia (1983) J Endocrinol Invest., 6 (6), pp. 493-505 Rajatanavin, R., Liberman, C., Lawrence, G.D., D'Arcangues, C.M., Young, R.A., Emerson, C.H., Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma (1985) J Clin Endocrinol Metab., 61 (1), pp. 17-21 Mariotti, S., Martino, E., Cupini, C., Lari, R., Giani, C., Baschieri, L., Low serum thyroglobulin as a clue to the diagnosis of hyperthyroidism factitia (1982) N Engl J Med., 307 (7), pp. 410-412 Luton, D., le Gac, I., Vuillard, E., Castanet, M., Guibourdenche, J., Noel, M., Management of Graves' disease during pregnancy: The key role of fetal thyroid gland monitoring (2005) J Clin Endocrinol Metab., 90 (11), pp. 6093-6098 Vos, X.G., Smit, N., Endert, E., Tijssen, J.G., Wiersinga, W.M., Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: A prospective study (2008) Clin Endocrinol (Oxf)., 69 (2), pp. 311-317 Al-Shariff, A., Abujbara, A.A., Chiacchio, S., Ajlouni, K.M., Mariani, G., Contribution of radioiodine uptake measurement and thyroid scintigraphy to the differential diagnosis of thyrotoxicosis (2010) Hell J Nucl Med., 13 (2), pp. 132-137 Baek, J.B., Lee, J.H., Valcavi, R., Pacella, C.M., Rhim, H., Gyu, D., Thermal ablation for benign thyroid nodules: Radiofrequency and laser (2011) Korean J Radiol., 12 (5), pp. 525-540 Burch, H.B., Wartofsky, L., Life-threatening thyrotoxicosis. Thyroid storm (1993) Endocrinol Metab Clin North Am., 22 (2), pp. 263-277 Akamizu, T., Satoh, T., Isozaki, O., Suzuki, A., Wakino, S., Iburi, T., Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys (2012) Thyroid., 22 (7), pp. 661-679 Laurberg, P., Vestergaard, H., Nielsen, S., Christensen, S.E., Seefeldt, T., Helleberg, K., Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases (2007) J Clin Endocrino Metab., 92 (6), pp. 2149-2156 Giles, H.G., Roberts, E.A., Orrego, H., Sellers, E.M., Disposition of intravenous propylthiouracil (1981) J Clin Pharmacol., 21 (11-12 PART 1), pp. 466-471 Nabil, N., Miner, D.J., Amatruda, J.M., Methimazole: An alternative route of administration (1982) J Clin Endocrino Metab., 54 (1), pp. 180-181 Walter Jr., R.M., Bartle, W.R., Rectal administration of propylthiouracil in the treatment of Graves' disease (1990) Am J Med., 88 (1), pp. 69-70 Yeung, S.C., Go, R., Balasubramanyam, A., Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm (1995) Thyroid., 5 (5), pp. 403-405 Jongjaroenprasert, W., Akarawut, W., Chantasart, D., Chailurkit, L., Rajatanavin, R., Rectal administration of propylthiouracil in hyperthyroid patients: Comparison of suspension enema and suppository form (2002) Thyroid., 12 (7), pp. 627-631 Hodak, S.P., Huang, C., Clarke, D., Burman, K.D., Jonklaas, J., Janicic-Kharic, N., Intravenous methimazole in the treatment of refractory hyperthyroidism (2006) Thyroid., 16 (7), pp. 691-695 Bogazzi, F., Martino, E., Dell'Unto, E., Brogioni, S., Cosci, C., Aghini-Lombardi, F., Thyroid color flow Doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis (2003) J Endocrinol Investigation., 26 (7), pp. 635-640 Baeza, A., Aguayo, J., Barria, M., Pineda, G., Rapid preoperative preparation in hyperthyroidism (1991) Clin Endocrinol (Oxf)., 35 (5), pp. 439-445 Robuschi, G., Manfredi, A., Salvi, M., Gardini, E., Montermini, M., d'Amato, L., Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease (1986) J Endocrinol Invest., 9 (4), pp. 287-291 Tsatsoulis, A., Johnson, E.O., Kalogera, C.H., Seferiadis, K., Tsolas, O., The effect of thyrotoxicosis on adrenocortical reserve (2000) Eur J Endocrinol., 142 (3), pp. 231-235 Solomon, B.L., Wartofsky, L., Burman, K.D., Adjunctive cholestyramine therapy for thyrotoxicosis (1993) Clin Endocrinol (Oxf)., 38 (1), pp. 39-43 Vyas, A.A., Vyas, P., Fillipon, N.L., Vijayakrishnan, R., Trivedi, N., Successful treatment of thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis (2010) Endocr Pract., 16 (4), pp. 673-676 Glaser, N.S., Styne, D.M., Organization of Pediatric Endocrinologists of Northern California Collaborative Graves' Disease Study Group. Predicting the likelihood of remission in children with Graves' disease: A prospective, multicenter study (2008) Pediatrics., 121, pp. e481-e488 Dötsch, J., Siebler, T., Hauffa, B.P., Doeker, B., Andler, W., Bettendorf, M., Diagnosis and management of juvenile hyperthyroidism in Germany: A retrospective multicenter study (2000) J Pediatr Endocrinol Metab., 13 (7), pp. 879-885 Poyrazoǧlu, S., Saka, N., Bas, F., Isguven, P., Dogu, A., Turan, S., Evaluation of diagnosis and treatment results in children with Graves' disease with emphasis on the pubertal status of patients (2008) J Pediatr Endocrinol Metab., 21 (8), pp. 745-751 Kaguelidou, F., Alberti, C., Castanet, M., Guitteny, M.A., Czernichow, P., Leger, J., French Childhood Graves' Disease Study Group. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment (2008) J Clin Endocrinol Metab., 93 (10), pp. 3817-3826 Barrio, R., López-Capapé, M., Martinez-Badás, I., Carrillo, A., Moreno, J.C., Alonso, M., Graves' disease in children and adolescents: Response to long-term treatment (2005) Acta Paediatr., 94 (11), pp. 1583-1589 Maia, A.L., Ward, L.S., Carvalho, G.A., Graf, H., McIel, R.M., McIel, L.M., Thyroid nodules and differentiated thyroid cancer: Brazilian consensus (2007) Arq Bras Endocrinol Metab., 51 (5), pp. 867-893 Abraham, P., Avenell, A., McGeoch, S.C., Clark, L.F., Bevan, J.S., Antithyroid drug regimen for treating Graves' hyperthyroidism (2010) Cochrane Database Syst Rev., 20, pp. CD003420 Léger, J., Gelwane, G., Kaguelidou, F., Benmerad, M., Alberti, C., Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease: National long-term cohort study (2012) J Clin Endocrinol Metab., 97 (1), pp. 110-119 Perrild, H., Grüters-Kieslich, A., Feldt-Rasmussen, U., Grant, D., Martino, E., Kayser, L., Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study (1994) Eur J Endocrinol., 131 (5), pp. 467-473 Mussa, G.C., Corrias, A., Silvestro, L., Battan, E., Mostert, M., Mussa, F., Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years (1999) J Pediatr Endocrinol Metab., 12 (4), pp. 537-541 Slyper, A.H., Wyatt, D., Boudreau, C., Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidismand delayed pituitary recovery (2005) J Pediatr Endocrinol Metab., 18 (6), pp. 597-602 Cassio, A., Corrias, A., Gualandi, S., Tato', L., Cesaretti, G., Volta, C., Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: Results of a collaborative study (2006) Clin Endocrinol (Oxf)., 64 (1), pp. 53-57 Sato, H., Harada, S., Yokoya, S., Tanaka, T., Asayama, K., Mori, M., Treatment for childhood-onset Graves' disease in Japan: Results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists (2007) Thyroid., 17 (1), pp. 67-72 Smith, J., Brown, R.S., Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication (2007) Thyroid., 17 (11), pp. 1103-1107 Rivkees, S.A., Stephenson, K., Dinauer, C., Adverse events associated with methimazole therapy of graves' disease in children (2010) Int J Pediatr Endocrinol., 2010, p. 176970 Lazar, L., Kalter-Leibovici, O., Pertzelan, A., Weintrob, N., Josefsberg, Z., Phillip, M., Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients (2000) J Clin Endocrinol Metab., 85 (10), pp. 3678-3682 Ota, H., Amino, N., Morita, S., Kobayashi, K., Kubota, S., Fukata, S., Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease (2007) Clin Endocrinol (Oxf)., 67 (1), pp. 41-45 Rivkees, S.A., Szarfman, A., Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children (2010) J Clin Endocrinol Metab., 95 (7), pp. 3260-3267 Sato, H., Hattori, M., Fujieda, M., Sugihara, S., Inomata, H., Hoshi, M., High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil (2000) J Clin Endocrinol Metab., 85 (11), pp. 4270-4273 Jafarzadeh, A., Poorgholami, M., Izadi, N., Nemati, M., Rezayati, M., Immunological and hematological changes in patients with hyperthyroidism or hypothyroidism (2010) Clin Invest Med., 33 (5), pp. 271-279 Sarinnapakorn, V., Noppavetchwich, P., Sunthorntepwarakul, T., Deerochanawong, C., Ngongamrut, S., Abnormal liver function test in Graves' disease: A prospective study of comparison between the hyperthyroid state and the euthyroid state (2011) J Med Assoc Thai., 94 (SUPPL. 2), pp. S11-S16 Sandrini, R., França, S.N., Lacerda, L., Graf, H., Treatment of hyperthyroidism in infancy and adolescence (2001) Arq Bras Endocrinol Metab., 45 (1), pp. 32-36 Hamerschlak, N., Maluf, E., Biasi Cavalcanti, A., Avezum Júnior, A., Eluf-Neto, J., Passeto Falcão, R., Incidence and risk factors for agranulocytosis in Latin American countries--the Latin Study: A multicenter study (2008) Eur J Clin Pharmacol., 64 (9), pp. 921-929 Takata, K., Kubota, S., Fukata, S., Kudo, T., Nishihara, E., Ito, M., Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily (2009) Thyroid., 19 (6), pp. 559-563 Salpeter, S.R., Ormiston, T.M., Salpeter, E.E., Cardioselective betablockers in patients with reactive airway disease: A meta-analysis (2002) Ann Intern Med., 137 (9), pp. 715-725 Sato, H., Minagawa, M., Sasaki, N., Sugihara, S., Kazukawa, I., Minamitani, K., Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: Efficacy and adverse reactions during initial treatment and long-term outcome (2011) J Pediatr Endocrinol Metab., 24 (5-6), pp. 257-263 Chen, D.Y., Chen, T.H., Comparison of efficacy of 131I and antithyroid drugs in the treatment of Graves' disease in children (2005) Chin J Pediatr., 43 (7), pp. 507-509 Bogazzi, F., Vitti, P., Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? (2008) Nat Clin Pract Endocrinol Metab., 4 (2), pp. 70-71 Hu, B., Wei, Y.F., Huang, C., Chen, L.X., The treatment strategy for pediatric Graves' disease and the relevant problems of radioiodine treatment (2006) J Med Forum., 27, pp. 67-68 Ma, C., Kuang, A., Xie, J., Liu, G., Radioiodine treatment for pediatric Graves' disease (2008) Cochrane Database Syst Rev., 16, pp. CD006294 Rivkees, S.A., Cornelius, E.A., Influence of iodine-131 dose on the outcome of hyperthyroidism in children (2003) Pediatrics., 111 (4 PART 1), pp. 745-749 Zantut-Wittmann, D.E., Ramos, C.D., Santos, A.O., Lima, M.M., Panzan, A.D., Facuri, F.V., High pre-therapy [99mTc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: Predictive factors of failure in [131I]iodide therapy in Graves' disease (2005) Nucl Med Commun., 26 (11), pp. 957-963 Nebesio, T.D., Siddiqui, A.R., Pescovitz, O.H., Eugster, E.A., Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children (2002) J Pediatr., 141 (1), pp. 99-103 Monte, O., Calliari, L.E.P., Longui, C.A., Utilização do 131I no tratamento da doença de Basedow-Graves na infância e adolescência (2004) Arq Bras Endocrinol Metab., 48 (1), pp. 166-170 Kalinyak, J.E., McDougall, I.R., How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? (2003) J Clin Endocrinol Metab., 88 (3), pp. 975-977 Kadmon, P.M., Noto, R.B., Boney, C.M., Goodwin, G., Gruppuso, P.A., Thyroid storm in a child following radioactive iodine (RAI) therapy: A consequence of RAI versus withdrawal of antithyroid medication (2001) J Clin Endocrinol Metab., 86 (5), pp. 1865-1867 Freitas, J.E., Swanson, D.P., Gross, M.D., Sisson, J.C., Iodine-131: Optimal therapy for hyperthyroidism in children and adolescents? (1979) J Nucl Med., 20 (8), pp. 847-850 Rivkees, S.A., Dinauer, C., An optimal treatment for pediatric Graves' disease is radioiodine (2007) J Clin Endocrinol Metab., 92 (3), pp. 797-800 Bogazzi, F., Bartalena, L., Brogioni, S., Mazzeo, S., Vitti, P., Burelli, A., Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis (1997) Thyroid., 7 (4), pp. 541-545 Imaizumi, M., Usa, T., Tominaga, T., Neriishi, K., Akahoshi, M., Nakashima, E., Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure (2006) JAMA., 295 (9), pp. 1011-1022 Cheetham, T.D., Hughes, I.A., Barnes, N.D., Wraight, E.P., Treatment of hyperthyroidism in young people (1998) Arch Dis Child., 78 (3), pp. 207-209 Feliciano, D.V., Lyons, J.D., Thyroidectomy is optimal treatment for Graves' disease (2011) J Am Coll Surg., 212 (4), pp. 714-720 Sugino, K., Ito, K., Nagahama, M., Kitagawa, W., Shibuya, H., Ito, K., Surgical management of Graves' disease-10-year prospective trial at a single institution (2008) Endocr J., 55 (1), pp. 161-167 Kriplani, A., Buckshee, K., Bhargava, V.L., Takkar, D., Ammini, A.C., Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy (1994) Eur J Obstet Gynecol Reprod Biol., 54 (3), pp. 159-163 Davis, L.E., Lucas, M.J., Hankins, G.D., Roark, M.L., Cunningham, F.G., Thyrotoxicosis complicating pregnancy (1989) Am J Obstet Gynecol., 160 (1), pp. 63-70 Millar, L.K., Wing, D.A., Leung, A.S., Koonings, P.P., Montoro, M.N., Mestman, J.H., Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism (1994) Obstet Gynecol., 84 (6), pp. 946-949 Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum The American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum (2011) Thyroid., 21 (10), pp. 1081-1125 Mandel, S.J., Cooper, D.S., The use of antithyroid drugs in pregnancy and lactation (2001) J Clin Endocrinol Metab., 86 (6), pp. 2354-2359 Clementi, M., Di Gianantonio, E., Pelo, E., Mammi, I., Basile, R.T., Tenconi, R., Methimazole embryopathy: Delineation of t Trzepacz, P.T., Klein, I., Roberts, M., Greenhouse, J., Levey, G.S., Graves' disease: An analysis of thyroid hormone levels and hyperthyroid signs and symptoms (1989) Am J Med., 87 (5), pp. 558-561 Geffner, D.L., Hershman, J.M., Beta-adrenergic blockade for the treatment of hyperthyroidism (1992) Am J Med., 93 (1), pp. 61-68 McDevitt, D.G., Nelson, J.K., Comparative trial of atenolol and propranolol in hyperthyroidism (1978) Br J Clin Pharmacol., 6 (3), pp. 233-237 Duggal, J., Singh, S., Kuchinic, P., Butler, P., Arora, R., Utility of esmolol in thyroid crisis (2006) Can J Clin Pharmacol., 13 (3), pp. 292-295 Henderson, J.M., Portmann, L., van Melle, G., Haller, E., Ghika, J.A., Propranolol as an adjunct therapy for hyperthyroid tremor (1997) Eur Neurol., 37 (3), pp. 182-185 Milner, M.R., Gelman, K.M., Phillips, R.A., Fuster, V., Davies, T.F., Goldman, M.E., Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms (1990) Pharmacotherapy., 10 (2), pp. 100-106 Kelestimur, F., Aksu, A., The effect of diltiazem on the manifestations of hyperthyroidism and thyroid function tests (1996) Exp Clin Endocrinol Diabetes., 104 (1), pp. 38-42 Cooper, D.S., Antithyroid drugs (2005) N Engl J Med., 352 (9), pp. 905-917 Russo, M.W., Galanko, J.A., Shrestha, R., Fried, M.W., Watkins, P., Liver transplantation for acute liver failure from drug induced liver injury in the United States (2004) Liver Transpl., 10 (8), pp. 1018-1023 Bahn, R.S., Burch, H.B., Cooper, D.S., Garber, J.R., Greenlee, M.C., Klein, I., Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists (2011) Endocr Pract., 17 (3), pp. 456-520 Shivakumar, S.K., Dwarakanath, S., Swaroop, G., Venkataramana, N.K., Aplasia cutis congenita of the scalp: Therapeutic modalities (2006) Neurol India., 54 (3), pp. 312-313 Reinwein, D., Benker, G., Lazarus, J.H., Alexander, W.D., A prospective randomized trial of antithyroid drug dose in Graves' disease therapy (1993) J Clin Endocrinol Metab., 76 (6), pp. 1516-1521 Pearce, S.H., Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK (2004) Clin Endocrinol (Oxf)., 61 (5), pp. 589-594 Williams, K.V., Nayak, S., Becker, D., Reyes, J., Burmeister, L.A., Fifty years of experience with propylthiouracil-associated hepatotoxicity: What have we learned? (1997) J Clin Endocrinol Metab., 82 (6), pp. 1727-1733 Fibbe, W.E., Claas, F.H.J., van der Star-Dijkstra, W., Schaafsma, M.R., Meyboom, R.H., Falkenburg, J.H., Agranulocytosis induced by propylthiouracil: Evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells (1986) Br J Haematol., 64 (2), pp. 363-373 Cooper, D.S., The side effects of antithyroid drugs (1999) The Endocrinologist., 9, pp. 457-467 Schleusener, H., Schwander, J., Fischer, C., Holle, R., Holl, G., Badenhoop, K., Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease (1989) Acta Endocrinol., 120 (6), pp. 689-701 Vitti, P., Rago, T., Chiovato, L., Pallini, S., Santini, F., Fiore, E., Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment (1997) Thyroid., 7 (3), pp. 369-375 Tamai, H., Nakagawa, T., Fukino, O., Ohsako, N., Shinzato, R., Suematsu, H., Thionamida therapy in Graves' disease: Relation of relapse rate to duration of therapy (1980) Ann Intern Med., 92 (4), pp. 488-490 Allannic, H., Fauchet, R., Orgiazzi, J., Madec, A.M., Genetet, B., Lorcy, Y., Antithyroid drugs and Graves' disease: A prospective randomized evaluation of the efficacy of treatment duration (1990) J Clin Endocrinol Metab., 70 (3), pp. 675-679 Benker, G., Rjenwein, D., Kahaly, G., Teglu, L., Alexander, W.D., Fassbinder, J., Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study (1998) Clin Endocrinol (Oxf)., 49 (4), pp. 451-457 Wood, L.C., Ingbar, S.H., Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents (1979) J Clin Invest., 64 (5), pp. 1429-1436 Hedley, A.J., Young, R.E., Jones, S.J., Alexander, W.D., Bewsher, P.D., Antithyroid drugs in the treatment of hyperthyridism of Graves' disease: Long-term follow-up of 434 patients (1989) Clin Endocrinol (Oxf)., 31 (2), pp. 209-218 Berglund, J., Christensen, S.B., Dymling, J.F., Hallengren, B., The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmo during the period 1970-1974 (1991) J Intern Med., 229 (5), pp. 435-442 Cruz Júnior, A.F., Takahashi, M.H., Albino, C.C., Tratamento clínico com drogas antitireoidianas ou dose terapêutica de Iodo-131 no controle do hipertireoidismo na doença de Graves: Avaliação dos custos e benefícios (2006) Arq Bras Endocrinol Metab., 50 (6), pp. 1096-1101 Hegedus, L., Treatment of Graves' hyperthyroidism: Evidencebased and emerging modalities (2009) Endocrinol Metab Clin North Am., 38 (2), pp. 355-371 Ross, D.S., Radioiodine therapy for hyperthyroidism (2011) N Engl J Med., 364 (6), pp. 542-550 Burch, H.B., Solomon, B.L., Cooper, D.S., Ferguson, P., Walpert, N., Howard, R., The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease (2001) J Clin Endocrino Metab., 86 (7), pp. 3016-3021 Andrade, V.A., Gross, J.L., Maia, A.L., The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: One-year follow-up of a prospective, randomized study (2001) J Clin Endocrinol Metab., 86 (8), pp. 3488-3493 Santos, R.B., Romaldini, J.H., Ward, L.S., Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease (2004) Thyroid., 14 (7), pp. 525-530 Imseis, R.E., Vanmiddlesworth, L., Massie, J.D., Bush, A.J., Vanmiddlesworth, N.R., Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism (1998) J Clin Endocrinol Metab., 83 (2), pp. 685-687 Bonnema, S.J., Bennedbaek, F.N., Gram, J., Veje, A., Marving, J., Hegedus, L., Resumption of methimazole after 131I therapy of hyperthyroid diseases: Effect on thyroid function and volume evaluated by a randomized clinical trial (2003) Eur J Endocrinol., 149 (6), pp. 485-492 Abraham, P., Acharya, S., Current and emerging treatment options for Graves' hyperthyroidism (2010) Ther Clin Risk Manag., 2 (6), pp. 29-40 Jarløv, A.E., Hegedüs, L., Kristensen, L.O., Nygaard, B., Hansen, J.M., Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? (1995) Clin Endocrinol (Oxf)., 43 (3), pp. 325-329 Leslie, W.D., Ward, L., Salamon, E.A., Ludwig, S., Rowe, R.C., Cowden, E.A., A randomized comparison of radioiodine doses in Graves' hyperthyroidism (2003) J Clin Endocrino Metab., 88 (3), pp. 978-983 Allahabadia, A., Dykin, J., Sheppard, M.C., Gough, S.C., Franklyn, J.A., Radioiodine treatment of hyperthyroidism-prognostic factors for outcome (2001) J Clin Endocrinol Metab., 86 (8), pp. 3611-3617 van Isselt, J.W., de Klerk, J.M., Lips, C.J., Radioiodine treatment of hyperthyroidism: Fixed or calculated doses intelligent design or science? (2007) Eur J Nucl Med Mol Imag., 34 (11), pp. 1883-1884 de Rooij, A., Vandenbroucke, J.P., Smit, J.W., Stokkel, M.P., Dekkers, O.M., Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: Systematic review and meta-analysis (2009) Eur J Endocrinol., 161 (5), pp. 771-777 Boelaert, K., Syed, A.A., Manji, N., Sheppard, M.C., Holder, R.L., Gough, S.C., Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism (2009) Clin Endocrinol (Oxf)., 70 (1), pp. 129-138 Abraham, P., Acharya, A., Current and emerging treatment options for Graves' hyperthyroidism (2010) Ther Clin Risk Manag., 6, pp. 29-40 Flower, M.A., al-Saadi, A., Harmer, C.L., McCready, V.R., Ott, R.J., Doseresponse study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy (1994) Eur J Nucl Med., 21 (6), pp. 531-536 Cooper, D.S., Hyperthyroidism (2003) Lancet., 362 (9382), pp. 459-468 Bogazzi, F., Giovannetti, C., Fessehatsion, R., Tanda, M.L., Campomori, A., Compri, E., Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: A cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal (2010) J Clin Endocrinol Metab., 95 (1), pp. 201-208 Metso, S., Auvinen, A., Huhtala, H., Salmi, J., Oksala, H., Jaatinen, P., Increased cancer incidence after radioiodine treatment for hyperthyroidism (2007) Cancer., 109 (10), pp. 1972-1979 Verburg, F.A., Luster, M., Lassmann, M., Reiners, C., (131)I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies (2011) Nuklearmedizin., 50 (3), pp. 93-99 Ceccarelli, C., Canale, D., Battisti, P., Caglieresi, C., Moschini, C., Fiore, E., Testicular function after 131I therapy for hyperthyroidism (2006) Clin Endocrinol., 65 (4), pp. 446-452 Stalberg, P., Svensson, A., Hessman, O., Akerstrom, G., Hellman, P., Surgical treatment of Graves' disease: Evidence-based approach (2008) World J Surg., 32 (7), pp. 1269-1277 Yip, J., Lang, B.H., Lo, C.Y., Changing trend in surgical indication and management for Graves' disease (2012) Am J Surg., 203 (2), pp. 162-167 Liu, J., Bargren, A., Schaefer, S., Chen, H., Sippel, R.S., Total thyroidectomy: A safe and effective treatment for Graves' disease (2011) J Surg Res., 168 (1), pp. 1-4 Nayak, B., Burman, K., Thyrotoxicosis and thyroid storm (2006) Endocr Metab Clin North Am., 35 (4), pp. 663-686 Ansaldo, G.L., Pretolesi, F., Varaldo, E., Meola, C., Minuto, M., Borgonovo, G., Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter (2000) J Am Coll Surg., 191 (6), pp. 607-612 Erbil, Y., Ozluk, Y., Giris, M., Salmaslioglu, A., Issever, H., Barbaros, U., Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease (2007) J Clin Endocrinol Metab., 92 (6), pp. 2182-2189 Bellantone, R., Lombardi, C.P., Raffaelli, M., Boscherini, M., Alesina, P.F., de Crea, C., Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? (2002) Surgery., 132 (6), pp. 1109-1112 Portefield Jr., J.R., Thompson, G.B., Farley, D.R., Grant, C.S., Richards, M.I., Evidence-based management of toxic multinodular goiter (Plummer' Disease) (2008) World J Surg., 32 (7), pp. 1278-1284 Winsa, B., Rastad, J., Akerstrom, G., Johansson, H., Westermark, K., Karlsson, F.A., Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy (1995) Eur J Endocrinol., 132 (4), pp. 406-412 Miccoli, P., Vitti, P., Rago, T., Iacconi, P., Bartalena, L., Bogazzi, F., Surgical treatment of Graves' disease: Subtotal or total thyroidectomy? (1996) Surgery., 120 (6), pp. 1020-1024 Palit, T.K., Miller III, C.C., Miltenburg, D.M., The efficacy of thyroidectomy for Graves' disease: A meta-analysis (2000) J Surg Res., 90 (2), pp. 161-165 Sosa, J.A., Bowman, H.M., Tielsch, J.M., Powe, N.R., Gordon, T.A., Udelsman, R., The importance of surgeon experience for clinical and economic outcomes from thyroidectomy (1998) Ann Surg., 228 (3), pp. 320-330 Stocker, D.J., Burch, H.B., Thyroid cancer yield in patients with Graves' disease (2003) Minerva Endocrinol., 28 (3), pp. 205-212 Kikuchi, S., Noguchi, S., Yamashita, H., Uchino, S., Kawamoto, H., Prognosis of small thyroid cancer in patients with Graves' disease (2006) Br J Surg., 93 (4), pp. 434-439 Camargo, R., Corigliano, S., Friguglietti, C., Gauna, A., Harach, R., Munizaga, F., Latin American thyroid society. Latin American thyroid society recommendations for the management of thyroid nodules (2009) Arq Bras Endocrinol Metab., 53 (9), pp. 1167-1175 Krohn, K., Führer, D., Bayer, Y., Eszlinger, M., Brauer, V., Neumann, S., Molecular pathogenesis of euthyroid and toxic multinodular goiter (2005) Endocr Rev., 26 (4), pp. 504-524 Franklyn, J.A., Boelaert, K., Thyrotoxicosis (2012) Lancet., 379 (9821), pp. 1155-1166 Becker, D.V., Hurley, J.R., Complications of radioiodine treatment of hyperthyroidism (1971) Semin Nucl Med., 1 (4), pp. 442-460 Koornstra, J.J., Kerstens, M.N., Hoving, J., Visscher, K.J., Schade, J.H., Gort, H.B., Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs (1999) Neth J Med., 55 (5), pp. 215-221 Papini, E., Guglielmi, R., Bianchini, A., Creszenci, A., Taccogna, S., Nardi, F., Risk of malignancies in non-palpable thyroid nodules: Predictive value of ultrasound and colo-Doppler features (2002) J Clin Endocrinol Metab., 87 (5), pp. 1941-1946 Graf, H., Pacini, F., Pinchera, A., Leung, A., Vaisman, M., Reiners, C., Modified-release recombinant human TSH (MRrhTSH) augments the effect of 131I therapy in benign multinodular goiter: Results from a multicenter international, randomized, placebo-controlled study (2011) J Clin Endocrinol Metab., 96 (5), pp. 1368-1376 Hegedus, L., Bonnema, S.J., Bennedbaek, F.N., Management of simple nodular goiter: Current status and future perspectives (2003) Endocr Rev., 24 (1), pp. 102-132 Zakavi, S.R., Mousavi, Z., Davachi, B., Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule (2009) Nucl Med Commun., 30 (2), pp. 169-175 Erickson, D., Gharib, H., Li, H., van Heerden, J.A., Treatment of patients with toxic multinodular goiter (1998) Thyroid., 8 (4), pp. 277-282 Wahl, R.A., Rimpl, I., Saalabian, S., Schabram, J., Differentiated operative therapy of thyroid autonomy (Plummer's disease) (1998) Exp Clin Endocrinol Diabetes., 106 (SUPPL. 4), pp. S78-S84 Kang, A.S., Grant, C.S., Thompson, G.B., van Heerden, J.A., Current treatment of nodular goiter with hyperthyroidism (Plummer's Disease): Surgery versus radioiodine (2002) Surgery., 132 (6), pp. 916-923 Vidal-Trecan, G.M., Stahl, J.E., Eckman, M.H., Radioiodine or surgery for toxic thyroid adenoma: Dissecting an important decision. A cost-effectiveness analysis (2004) Thyroid., 14 (11), pp. 933-945 Vaiman, M., Nagibin, A., Hagag, P., Kessler, A., Gavriel, H., Hypothyroidism following partial thyroidectomy (2008) Otolaryngol Head Neck Surg., 138 (1), pp. 98-100 Lippi, F., Ferrari, C., Manetti, L., Rago, T., Santini, F., Monzani, F., Treatment of solitary authonomous thyroid nodules by percutaneous ethanol injection: Results of an Italian multicenter study. The Multicenter Study Group (1996) J Clin Endocrinol Metab., 81 (9), pp. 3261-3264 Braga-Basaria, M., Trippia, M.A., Stolf, A.R., Mesa Jr., C., Graf, H., Treatment of autonomous and cystic thyroid nodules with intranodular ethanol injection (2002) Rev Assoc Med Bras., 48 (4), pp. 335-340 Yano, Y., Sugino, K., Akaishi, J., Uruno, T., Okuwa, K., Shibuya, H., Treatment of autonomously functioning thyroid nodules at a single institution: Radioiodine therapy, surgery, and ethanol injection therapy (2011) Ann Nucl Med., 25 (10), pp. 749-754 Monzani, F., Caraccio, N., Goletti, O., Lippolis, P.V., Casolaro, A., del Guerra, P., Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: A study of 117 patients (1997) Clin Endocrinol (Oxf)., 46 (1), pp. 9-15 Janowitz, P., Ackmann, S., Long-term results of ultrasound-guided ethanol injections in patients with autonomous thyroid nodules and hyperthyroidism (2001) Med Klin (Munich)., 96 (8), pp. 451-456 Valcavi, R., Frasoldati, A., Ultrasound-guided percutaneous etanol injection therapy in thyroid cystic nodules (2004) Endocr Pract., 10 (3), pp. 269-275 Tarantino, L., Francica, G., Sordelli, I., Sperlongano, P., Parmeggiani, D., Ripa, C., Percutaneous ethanol injection of hyperfunctioning thyroid nodules: Long-term follow-up in 125 patients (2008) AJR Am J Roentgenol., 190 (3), pp. 800-808 Dossing, H., Bennebaek, F.N., Karstrup, S., Hegedüs, L., Benign solitary solid cold thyroid nodules: US-guided interstitial laser photocoagulation-initial experience (2002) Radiology., 225 (1), pp. 53-57 Papini, E., Guglielmi, R., Bizarri, G., Pacella, C.M., Ultrasound-guided laser termal ablation for treatment of benign thyroid nodules (2004) Endocrine Practice., 10 (3), pp. 276-283